Skip to content

Animated Cartoons and Cooperation in Young Children Receiving Inhaled Medications

Effectiveness of Animated Cartoons for Improving Cooperation During the Delivery of Inhaled Treatments to Young Children With Asthma

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02879240
Acronym
DISTRACT
Enrollment
11
Registered
2016-08-25
Start date
2016-08-31
Completion date
2017-03-31
Last updated
2017-06-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patient Compliance, Inhalation Spacers

Brief summary

Up to 50% of infants and young children cry during the administration of their inhaled treatment for their asthma. This results in decreased lung deposition, and thus decreased effectiveness of their inhaled treatment. The objective of this study is to evaluate whether animated cartoons can increase the cooperation of young children with asthma who are not cooperative during the delivery of their ICS therapy through a pMDI/spacer.

Interventions

An animated cartoon chosen by the parents is displayed on a smartphone attached on the spacer of the child.

OTHERBlack screen

A video displaying a black screen is used as control, and displayed on a smartphone attached on the spacer of the child.

Sponsors

Hôpital Necker-Enfants Malades
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Months to 47 Months
Healthy volunteers
Yes

Inclusion criteria

* Dyad parent-child. * Parent must be 18 years or older and own a smartphone which can record videos and display animated cartoons. * Child must be 6-47 months old, and require an inhaled corticosteroid therapy, and use a pressurized metered-dose inhaler and a spacer, and have difficulties in cooperation at least half of the time on the last week.

Exclusion criteria

* Children with a medical history of epilepsy, or visual or hearing impairment not corrected by an appropriate device/treatment. * Parents not speaking French or English. * Parents not able to run the mobile application used to record the videos of the child despite repeated explanations.

Design outcomes

Primary

MeasureTime frameDescription
Fraction of time during which the child is non-cooperativeAt the end of the three weeks (day 21)Length of time during which the child is crying or moving outside the mask, divided by the total length of time needed for the delivery of the inhaled treatment

Secondary

MeasureTime frameDescription
Fraction of time during which the child is cryingAt the end of the three weeks (day 21)Length of time during which the child is crying divided by the total length of time needed for the delivery of the inhaled treatment
Fraction of time during which the child is moving outside the maskAt the end of the three weeks (day 21)Length of time during which the child is moving outside the mask divided by the total length of time needed for the delivery of the inhaled treatment

Other

MeasureTime frame
Hetero-evaluation of the cooperation of the child by the parentAt the end of the three weeks (day 21)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026